Tisch MSRCNY Stem Cell Trial Featured on Neurology Advisor

Last week during the American Academy of Neurology (AAN) Annual Meeting, Neurology Advisor sat down with Dr. Saud A. Sadiq to discuss the results of Tisch MSRCNY's Phase I Stem Cell Trial for MS. Please visit the link below to read: Stem Cell-Derived Therapy Shows Promise in Progressive Multiple Sclerosis. http://www.neurologyadvisor.com/aan-2016-coverage/intrathecal-neural-progenitor-therapy-for-ms/article/490823/

News Date : 
Tuesday, April 26, 2016 (All day)

IMSMP

Because you deserve only the best in MS healthcare. Experience the difference.

Newsletter Sign Up

Join our mailing list today!  Receive the latest information and updates happening in MS research, treatment and care including, Healing MS, the IMSMP newsletter.

* We don’t share your information with anyone.